Table 1.
Clinical characteristics and imaging findings of 67 hemophilia A patients.
| Clinical characteristics/Imaging Findings | Patients |
|---|---|
| Median age (range), years | 36.3 (16–69) |
| Primary and secondary prophylaxis treatment, n (%) | 8 (12.0%) |
| Tertiary prophylaxis treatment, n (%) | 22 (32.8%) |
| On demand treatment, n (%) | 37 (55.2%) |
| Viral infections,n (%) | |
| HCV-RNA | 29 (43.3%) |
| Anti-HCV | 43 (64.2%) |
| HIV | 14 (20.9%) * |
| Hemarthroses,n (%) | |
| <10 | 7 (10.4%) |
| 10–50 | 17 (25.4%) |
| >50 | 43 (64.2%) |
| Synovial hypertrophy,n (%) | |
| ≤2.5 mm | 40 (59.7%) |
| >2.5 mm | 27 (40.3%) |
| Clinical WFH score, mean ± SD | 37.6 ± 21.2 |
| RadiographicPettersson score, mean ± SD | 8.46 ± 7.62 |
| US score, mean ± SD | 8.32 ± 4.09 |
| n (%) | |
| <5 | 15 (22.4%) |
| ≥5 | 52 (77.6%) |
WFH: World Federation of Hemophilia; US: ultrasound. * All HIV positive with undetectable viremia (HIV-RNA < 20 cp/mL) and receiving antiretroviral therapy.